The human tear film is a highly ordered structure consisting of a thin layer of lipid on the surface and a thicker aqueous-mucin phase, which increases in mucin concentration toward the corneal epithelial cell layer. The health of the tear film and ocular surface influences the likelihood of being able to achieve successful contact lens wear. Contact lens discomfort and dryness are the most frequent reasons why contact lens wearers experience reduced wearing times, which can eventually lead to contact lens discontinuation. Comprehensive clinical assessment of tear film integrity and ocular surface health is therefore essential prior to commencing contact lens wear, to enable the ocular surface environment to be optimised to support lens wear. These parameters should also be evaluated over the course of contact lens wear, in order to identify any aspects requiring clinical management and ensure maintenance of optimal lens-wearing conditions. This review summarises current knowledge relating to the effects of soft contact lens wear on the tear film and ocular surface. It also provides a systematic approach to evaluating tear film and ocular surface integrity, in order to guide the clinical management of tear film anomalies with respect to contact lens wear.
The tear film is a complex, precisely ordered fluid structure comprising a thin outer layer of lipid and a thicker underlying aqueous-mucin phase, with increasing mucin concentration toward the corneal epithelial cell layer. A thin layer of membrane-bound mucin, glycocalyx, imparts hydrophilicity to the hydrophobic corneal surface. 1 In excess of 1,000 proteins or fractions of proteins have been identified within the human tear film. 2, 3 The tear fluid also contains a variety of regulated inflammatory mediators, including by-products of arachidonic acid metabolism, the complement cascade, cytokines and components derived from the ocular microbiome. 3, 4 The integrity of the tear film can strongly influence the likelihood of achieving successful contact lens wear. Contact lens discomfort and dryness are the most frequent reasons why contact lens wearers experience reduced wearing times, which can eventually lead to contact lens discontinuation. 5 Comprehensive clinical assessment of tear film quality and quantity, and ocular surface health are therefore essential both prior to commencing contact lens wear, to enable the ocular surface environment to be optimised to support lens wear, and over the course of lens wear, to identify any aspects requiring clinical attention to maintain optimal lens-wearing conditions. This review summarises current knowledge relating to the effects of soft contact lens wear on tear film composition, and outlines an approach to evaluating tear film and ocular surface integrity, to guide the clinical management of tear film anomalies with respect to contact lens wear.
ASSESSING THE TEAR FILM AND OCULAR SURFACE IN CONTACT LENS WEAR: A SYSTEMATIC APPROACH
Using techniques such as interferometry, tomography and spectral reflectance, normal tear film thickness over the central cornea has been shown to be approximately three microns, with mild variations during each blink cycle. 6, 7 Tear turnover rate, which mostly relates to replenishing the tear aqueous layer, is about 16 per cent per minute. 8, 9 The application of a contact lens to the eye can alter both the integrity of the tear film and the ocular surface microenvironment. A contact lens artificially compartmentalises the tear film into pre-and post-lens layers in situ, affecting its biochemical and biophysical characteristics, and reducing tear stability. 10 At approximately two microns thick, the prelens tear film is thinner than the pre-corneal tear film by about one micron, 6, 7 likely predisposing the tear fluid to more rapid destabilisation. It follows that sensations of ocular dryness and symptoms of discomfort occur commonly in contact lens wearers. 11 Contact lens wearers tend to experience these symptoms more frequently than non-lens wearers, 12, 13 with discomfort and dryness being the two primary reasons for lens intolerance and discontinuation.
14 Asymptomatic contact lens wearers show a higher basal tear flow rate than symptomatic wearers, perhaps helping to counteract the loss of tear fluid from the higher tear evaporation rate in contact lens wear. important components of this clinical evaluation. 12, 14, 16 In Table 1 , an approach to comprehensively assess the tear film and ocular surface health in contact lens patients is proposed. This approach considers both 'core' techniques, which are frequently used in practice and provide key information to inform clinical care, and 'supplementary' techniques, which can potentially be used to refine disease management but may require specialist clinical instrumentation.
In the following section, each of the components of the tear film and ocular surface assessment detailed in Table 1 are considered. The effects of soft contact lens wear on each tear film component are also discussed in Table 2 . Table 2 summarises key changes in the tear film with contact lens wear. The degree of change will depend on a variety of factors, including the contact lens type and care system used. Findings that have been associated with contact lens discomfort are shown in bold type.
THE PROCESS OF ASSESSING THE TEAR FILM AND OCULAR SURFACE IN CONTACT LENS PRACTICE

Clinical history and symptom assessment
An initial ophthalmic examination will begin with a thorough history and exploration of the patient's presenting symptoms. Qualitative symptom assessment is highly favoured by clinicians in the evaluation of ocular surface disease, although this is often undertaken without standardisation. [49] [50] [51] [52] [53] [54] Symptoms commonly associated with dry eye disease, for example eye burning, grittiness, foreign body sensation and scratchiness, also frequently occur in contact lens wearers. These symptoms are useful for guiding the clinician to undertake directed questioning that may assist with the identification of personal and/or environmental risk factors for ocular discomfort.
Patient-related factors known to be associated with contact lens discomfort include younger age, female sex, poor tear film integrity, seasonal allergy and some systemic medications.
14 Cigarette smoking is a risk factor for tear instability and ocular surface damage, which may adversely impact contact lens comfort, 55 as well as increase the risk of microbial keratitis in daily lens wear. 55, 56 Changes to ocular comfort are commonly used clinically to assess the response of a patient to therapy, and as outcome measures for contact lens clinical trials. The frequency and/or severity of ocular discomfort symptoms can be measured using standardised questionnaires, although recent research suggests that these have relatively low uptake in clinical practice. 49, 54 While several questionnaires exist to measure dry eye symptoms in non-lens wearers, the Contact Lens Dry Eye Questionnaire (CLDEQ-8) is currently the main tool for specifically quantifying discomfort in contact lens wearers ( Figure 1) . 57 This survey has been validated and captures information over the preceding fortnight relating to eye discomfort and dryness, changeable and blurry vision, and the effects of eye closure and contact lens removal. Changes to the CLDEQ-8 score are considered to reflect a lens wearer's global opinion of lens comfort. 57 
Objective clinical assessments
A challenge in the clinical work-up of contact lens wearers is the potential discordance between symptoms and clinical signs. 58 Moreover, the assessment of symptomatology may not necessarily identify a proportion of people with clinical indicators of tear film dysfunction. For these reasons, objective assessments to detect asymptomatic tear abnormalities form an integral component of a comprehensive clinical examination, to enable prophylactic intervention(s). As indicated in Table 1 , the order of clinical testing should be considered carefully to ensure that test results are minimally affected by preceding tests, and thus should progress from relatively least invasive, for example non-invasive imaging and tear osmolarity, to most invasive, for example ocular surface staining and Schirmer test.
GENERAL ANTERIOR EYE ASSESSMENT
A general slitlamp biomicroscopic examination will typically occur before specific tests to examine the health of the tear film and ocular surface. Some of the important parameters that should be assessed, ideally with the use of standardised grading scales, for example, Efron, and Brien Holden Vision Institute (BHVI), which include the following.
• Ocular redness Bulbar redness is a non-specific sign that can be associated with a diverse range of ocular surface conditions, including allergy, exposure, inflammation, dryness and infection. As the depth, location and pattern of the vasodilatory response can differ depending on the aetiology, noting these features is useful for guiding the diagnosis. The severity of bulbar redness can be quantitatively assessed by clinicians using standardised grading scales or with automated image analysis, which is available in some anterior eye imaging devices. 59 In contact lens wearers, limbal hyperaemia, which results from dilation of the limbal vasculature, should be carefully evaluated, as this sign is related to the extent of oxygen transmissibility of contact lens materials and can indicate corneal hypoxia. 60, 61 • Eyelid assessment ( Figure 2 ) The eyelids should be observed carefully for signs of abnormalities, such as redness, oedema, telangiectasia, concretions, keratinisation, thickening and/or irregularity. 62 With respect to the eyelashes, features such as madarosis, poliosis and/or trichiasis should be identified, as these signs are often associated with meibomian gland dysfunction (MGD). The eyelids should be evaluated for crusting, consistent with anterior blepharitis, including signs of Demodex (Demodex folliculorum) blepharitis where cylindrical collarettes are frequently observed 63 ( Figure 3) . Notching of the margin of the lower eyelid ( Figure 4 ) may indicate the presence of long-standing meibomian gland disease, with localised gland atrophy. 64 The superior eyelid should be everted to assess for a tarsal conjunctival papillary response. In contact lens wearers, papillary conjunctivitis can occur as a consequence of a mechanical/hypersensitivity response to lens surface deposits. Management of this condition typically requires a period without contact lens wear and, depending on its severity, may need therapeutic intervention and/or refitting with a different contact lens material. 65 Similar tarsal conjunctival changes can occur in seasonal allergic conjunctivitis, which should be considered as a differential diagnosis. • Tear meniscus height (TMH) using slitlamp and/ or anterior eye photography
• TMH using OCT 4. Non-invasive tear stability assessment and lipid layer assessment
• Non-invasive tear break-up time (NIBUT) (e.g. Oculus Keratograph 5M, Medmont E300 topographer)
• Lipid layer assessment at the slitlamp biomicroscope, using specular reflection and a qualitative grading scale 98, 99 • Interferometry (e.g. Tearscope, Polaris, EASYTEARview+, Oculus Keratograph 5M, Kowa DR-1)
• Lipid layer thickness (e.g. LipiView II) 5 . Conjunctival integrity
• Impression cytology (e.g. goblet cell density)
• In vivo confocal microscopy 6 . Tear stability (invasive)
• Traditional TBUT, quantified with sodium fluorescein (NaFl) 7 . Ocular surface staining
• Corneal and conjunctival NaFl (with Wratten-12 yellow barrier filter) and lissamine green (LG) staining
• Use of standardised grading scales to assess the severity of NaFl (with Wratten-12 yellow barrier filter) and LG staining (e.g. BHVI, Efron, Oxford, van Bijsterveld) 8 . Invasive tear volume assessment
• Schirmer test (I, II)
• Phenol red thread test 9 . Blinking evaluation
• Blink rate and completeness (clinician observation)
• Ocular Protection Index (OPI)
• Assess for the presence of other eyelid abnormalities (e.g. lagophthalmos, positional anomalies)
• Korb-Blackie transillumination test for lagophthalmos 17 • 
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• Tear film The general quality of the tear film should be examined to assess for the presence of tear film anomalies, such as frothing and foaming. Individuals with earlier stages of MGD may have a foamy tear film, which is particularly evident within the inferior tear meniscus ( Figure 5 ). The tear film electrolyte concentration, as a measure of tear compositional integrity, can be formally measured by assaying tear osmolarity. Tear hyperosmolarity, which defines a state of relatively high tear osmotic solute concentration, is a well-established feature of dry eye disease. A threshold value of 316 mOsmol/L has been reported to provide a sensitivity of 73 per cent and specificity of 90 per cent for diagnosing clinically significant dry eye disease. 67 Tear osmolarity measurements can be undertaken in the clinic with the use of the TearLab system (TearLab Inc., San Diego, California, USA), which measures osmolarity from the electrical impedance of a 50 nl tear sample. Tear osmolarity measures should be performed in a temperature-regulated environment prior to the instillation of any eye-drops, or the application of invasive test procedures. 68 A finding of elevated tear osmolarity should alert the clinician to the potential for underlying dry eye disease, and the inflammatory response that is known to be associated with this finding. 69 Management of pre-existing tear film dysfunction should be undertaken prior to the commencement of contact lens wear. Beyond the adaptation period, soft contact lens wear does not appear to significantly alter tear osmolarity levels. 70, 71 Experimental studies have shown that total tear protein concentration, the levels of lactoferrin and lysozyme, are not significantly affected by contact lens wear. 15, 72 Tear film albumin levels are also relatively unchanged, Tear film parameter Reported change(s) with CL wear
Thickness
• Pre-lens tear film is approximately two microns in thickness, compared with a pre-corneal film thickness of about three microns in a non-lens wearing eye 6, 7 
Stability
• More rapid tear film thinning 18 and destabilisation; 10 decreased tear film stability is associated with CL discomfort [19] [20] [21] [22] • Higher rate of tear evaporation, 23 which may potentially be associated with decreased comfort in new wearers fitted with hydrogel lenses 24 • Reduced pre-lens non-invasive tear break-up time 25, 26 • Altered pre-lens tear film kinetics, which is associated with lens discomfort 27 
Lipid
• Thinner lipid layer; 25, 26 impaired lipid layer integrity and spreading correlates with symptoms of contact lens discomfort 28, 29 • Decrease in number of functional meibomian glands, particularly in the superior eyelid 30 • Alterations to meibum quality and more extensive meibomian gland orifice plugging 31 
Aqueous
• Reduced tear meniscus volume; 7 lower tear volume has a weak but statistically significant association with CL discomfort 32 
Mucin
• Reduction in goblet cell density with hydrogel CL wear that is associated with CL dryness symptoms 33 • Decrease in the amount of secreted mucin at the ocular surface;
10 the pattern of mucin degradation during contact lens wear may affect lens comfort 34 • Compression and thinning of the ocular surface glycocalyx layer 35 • Altered mucin expression and shedding, with contact lens multipurpose solutions 36 • Mucin balls 37 
Other
• Increased albumin concentration in closed-eye CL wear 38 • Reduced blinking frequency or an increased percentage of incomplete blinks are linked to lens discomfort 39, 40 • Changes to tear cytokines have been documented, although the specific profile of cytokine changes is unclear and any potential links to lens discomfort are not conclusive 41, 42 • Tear exchange is decreased 43, 44 • Tear pH is reduced 45, 46 • Tear film temperature: pre-lens tear film is cooler 47 and post-lens tear film is warmer 48 Table 2 . Summary of key changes to the tear film in contact lens (CL) wear and (in bold) their potential association with contact lens discomfort except in closed eye environments, for example extended contact lens wear, where an increase in albumin concentration has been reported. 38 In terms of the effect of contact lens wear on tear cytokine levels, several studies have sought to investigate these changes, with divergent findings. 41, 42 Currently, the role of inflammation in contact lens discomfort is controversial. 73 A recent study that longitudinally evaluated Langerhans cells, being antigen-presenting immune cells, in the cornea and conjunctiva demonstrated an initial transient increase in the density of these cells in people experiencing contact lens-induced discomfort; the same effect was not observed in asymptomatic contact lens wearers, suggesting a potential inflammatory component to the aetiology of the condition. 74 In addition, the presence of degraded lipids, leukotriene B4 and peroxidation products, and the enzyme secretory phospholipase A2 in tears has been associated with contact lens-induced discomfort. 73 The microbiome is altered in contact lens wear with observation of increased Gramnegative bacteria. 75, 76 A recent study found that in contact lens wearers there were a higher proportion of sterile (no aerobic) counts resulting from cultures taken from the eyelid margins, before and after meibomian gland expression, compared with non-lens wearers. 77 
EVALUATION OF THE TEAR FILM LIPID LAYER
The tear lipid layer is about 50 to 100 nm thick and derives mostly from the meibomian glands (in the form of meibum), with lesser contributions from the glands of Moll and Zeiss. 78, 79 The lipid layer of the tears has a duplex structure, consisting of a thin polar layer that interfaces with the aqueous layer and a thicker, non-polar The origin of the polar lipids that interface with the aqueous tear component remains debated, but may be distinct from the meibomian glands. 81 A major role of the lipid layer is to retard evaporation of the aqueous layer; the absence of a continuous lipid layer is reflected by a four-fold increase in the rate of tear evaporation. 82 Tear lipids also lower tear surface tension to prevent the spillage of the tears over the margins of the eyelids. 28 Tear film stability A key property of a healthy tear film is that it has sufficient stability to protect the ocular surface from desiccation during the interblink interval. Disruption to the tear film structure is clinically expressed as a reduction in tear film stability; this promotes increased evaporation of the tears, ultimately leading to tear film hyperosmolarity. 83 Aqueous deficiency and excessive evaporation, as the major aetiological classes of dry eye disease defined by the Tear Film and Ocular Surface (TFOS) International Dry Eye Workshop (2007), often co-exist; however, an evaporative component is reported in up to 86 per cent of dry eye presentations. 84 Intrinsic and extrinsic factors that disrupt the lipid layer can result in increased tear film evaporation. 83 Lipases within bacterial exotoxins can destabilise the lipid layer in anterior blepharitis, while blocked glands, a hallmark feature of obstructive MGD, lead to lipid insufficiency. As tear stability is associated with the level of comfort during contact lens wear, 10 assessing tear film stability is an important part of a contact lens clinical assessment.
Clinically, the most popular method for assessing tear stability is using the tear film break-up time (TBUT) parameter. Traditionally, measuring TBUT involves instilling a small volume of sodium fluorescein into the eye and observing the tear film using the slitlamp biomicroscope, with blue illumination and a Wratten-12 yellow-barrier filter. TBUT is the length of time (in seconds) between a full, natural blink and the first dark spot (break) becoming visible in the pre-corneal tear film. 85, 86 In Caucasian populations, a TBUT less than 10 seconds has been reported to be an indicator of an unstable tear film. 87 Indicative of the precorneal tear film being inherently less stable in individuals of Asian ethnicity, a seven second TBUT cut-off value has been proposed from studies of this population. 88 However, the measurement of TBUT using sodium fluorescein has significant limitations. The requisite instillation of fluid into the eye impacts on physiological tear stability 87 and measurement accuracy is influenced by a range of factors, including the pH and volume of the fluid instilled, 89 the brightness of the slitlamp illumination and the expertise of the clinician performing the measurement. 90 Given these limitations, there has been increasing scientific and clinical interest in measuring tear film stability using relatively less invasive techniques (Table 1) . Importantly, non-invasive tear break-up time (NIBUT) normative values vary between different clinical instruments and will not necessarily correlate with TBUT measures quantified using sodium fluorescein. 91, 92 For the Tearscope (Keeler Ophthalmic Instruments, Windsor, UK), which uses broadband illumination to enable a clinical examiner to visualise the tear film kinetics and determine NIBUT using interferometry, a cut-off value of 10 seconds has a reported sensitivity of 82 per cent and specificity of 86 per cent for diagnosing dry eye in Caucasian populations. However, an acknowledged limitation of this, and similar devices, is the subjective nature of the NIBUT measurement, which introduces the potential for intra-and inter-observer measurement variability. 93, 94 Automated systems for NIBUT quantification are now available; devices with this capability include the Oculus Keratograph 5M (Oculus Inc., Wetzlar, Germany) ( Figure 6A ) and Medmont E300 corneal topographer (Medmont International, Melbourne, Victoria, Australia) ( Figure 6B ).
Conflicting findings exist in relation to the capacity for the Oculus NIBUT to differentiate between individuals with dry eye disease and those with healthy tear films.
95,96
One study investigating the utility of the Medmont device for diagnosing dry eye suggests that a parameter related to NIBUT, the Tear Film Surface Quality Break-Up Time (TFSQ-BUT), has a potentially high sensitivity (82 per cent) and specificity (94 per cent) for identifying tear hyperosmolarity in people with dry eye disease, using a criterion of 12 seconds. 91, 92 Tear stability can also be quantified from the surface of a contact lens, to measure the degree of lens wettability. Contact lens wear thins the tear lipid layer, leading to a relative decrease in pre-lens NIBUT, 25 ,26 a greater rate of tear evaporation, 23 and quicker tear thinning, 18 compared with the pre-corneal film. Gradual accumulation of surface deposits on a contact lens will tend to exacerbate the effects of poor pre-lens wetting, reflected in low pre-lens tear film stability, and emphasising the need to optimise lens maintenance procedures and encourage regular lens replacement.
Symptomatic soft contact lens wearers show differences in their pre-lens tear film kinetics compared with those of asymptomatic lens wearers. In a retrospective analysis of clinical data, symptomatic soft lens wearers had reduced surface coverage of the lens by the tear film during the interblink period and a higher proportion of Tear film in soft contact lens wear Downie and Craig surface exposure at the time of blink than asymptomatic soft lens wearers. 27 Pre-lens tear film dynamics could be valuable for evaluating the efficacy of management strategies aimed at improving the stability of the pre-lens tear film.
Lipid layer evaluation
Interference fringes created by light interactions at the various tear layer interfaces can allow the lipid layer thickness and quality to be interferometrically estimated. By reflecting a wide-field, cold white light source from the tear film surface, patterns are generated within the lipid film. The patterns are generally monochromatic but coloured fringes become visible if the lipid film approaches or exceeds 100 nm in thickness. The range of patterns visible interferometrically cannot be achieved with standard slitlamp biomicroscopy.
While precise lipid thickness quantification is within the realm of single wavelength interferometers, 97 the patterns seen clinically by white light interferometry reveal characteristics consistent with a range of lipid thicknesses, and are classified according to published grading scales. 85, 98 The dynamic nature of the lipid layer can also be appreciated from the reflection of Placido mires on videokeratographic devices, such as the Oculus Keratograph 5M. Commercial interferometers include the DR-1 100 (Kowa, Nagoya, Japan), which allows subjective evaluation of a full-field lipid pattern and the LipiView II 101 (TearScience Inc., Morrisville, North Carolina, USA), which objectively quantifies the lipid thickness over a lower portion of the exposed ocular surface.
Meibum quality and ease of expression
Although there may be no significant difference in the prevalence of MGD between contact lens wearers and non-lens wearers, 102, 103 contact lenses can impact the morphological and functional integrity of the meibomian glands, particularly in the upper eyelid. 30 Contact lens wear has been associated with a decrease in the number of functional meibomian glands that is proportional to the duration of lens wear. 30 It is uncertain whether contact lens wear per se alters meibum composition and/or whether there is a relationship between meibum composition and contact lens comfort.
A recent cross-sectional study that compared meibomian gland characteristics in soft contact lens wearers and non-lens wearers reported that contact lens use was associated with abnormal meibum quality and more extensive meibomian orifice plugging. 31 Meibum quality scores were strongly negatively correlated with the duration of contact lens wear. 31 These findings emphasise the importance of routinely evaluating meibomian gland integrity, including expressibility, to enable early intervention for any underlying, or progressing, MGD.
One of the major recommendations of the TFOS International Workshop on Meibomian Gland Dysfunction (2011) was for meibomian gland expression to be routinely performed diagnostically by eyecare clinicians, even in asymptomatic adults. 62 To avoid excessive force, as may occur with digital expression, and to ensure consistency in the level of force applied to the meibomian gland, an expression device has been developed by Korb and Blackie (Meibomian Gland Evaluator, TearScience Inc., USA). The Meibomian Gland Evaluator ( Figure 9 ) enables the clinician to apply • Globular appearance indicates highly variable lipid thickness across the surface
• Commonly observed in meibomian gland dysfunction
• Indicates poor ability to inhibit tear film evaporation
• Patients with this pattern require lid disease management, prior to contact lens fitting Table 3 . Tear film lipid layer grading scale using white light interferometry Figure 7 . A thick lipid layer (>100 nm) shows first-order coloured fringes on interferometric observation of the tear film lipid layer Figure 8 . In meibomian gland dysfunction, poor lipid quality is reflected in an irregular interferometric pattern with bright colours, signifying clumps of lipid adjacent to areas with minimal or no lipid cover Figure 9 . The Meibomian Gland Evaluator applies a known pressure on the lid margin to provide a diagnostic assessment of gland expressibility. The image shows expression of thickened meibum from a single meibomian gland. ) to the glands that approximates the force exerted by the eyelids on the globe during blinking. 104 The device allows simultaneous expression of about eight meibomian glands. The extent of gland expressibility can then be scored based on the number of glands that yield fluid secretions. 105 Meibomian gland expressibility is known to be region-dependent, with nasal glands generally more expressible than temporally positioned glands. 104 If manual digital expression is performed, the degree of meibomian gland expressibility can be quantified using a semi-quantitative scale, which considers: a. the amount of pressure required to express the glands (from 1-3, where 1 = light, 2 = moderate and 3 = heavy) b. the quality of the expressed meibum (from 0-3, where 0 = clear, 1 = cloudy, 2 = granular and 3 = toothpaste) and c. the volume of secreted meibum (where the diameter of the largest pool expressed is measured in millimetres).
106,107
Deposition of tear film lipids onto the surface of contact lenses can occur with all contact lenses but is particularly evident with some silicone hydrogel materials. The lipid deposition on contact lenses can differ, both in terms of the amount and distribution, in contact lens wearers with healthy meibomian glands compared with those having MGD. 108 Specifically, the lipids extracted from individuals with MGD tend to deposit irregularly on the surface of a contact lens, whereas lipids from patients with healthy glands deposit relatively uniformly on the contact lens surface. 108 Further research is needed to determine the extent of inter-individual variability in meibum composition, whether this relates to contact lens comfort and how contact lens wear potentially alters meibum composition.
Meibography
Morphological assessment of the meibomian glands, for both the inferior and superior eyelids, can be achieved in the clinic by transilluminating the eyelid (meiboscopy) or using photodocumentation with infrared light (meibography). 107 A number of non-contact meibography devices are available, including the EASYTEARview+ (EASYTEAR, Trento, Italy), LipiView II (TearScience Inc., USA), Oculus Keratograph 5M (Oculus Inc., Wetzlar, Germany) and the Topcon BG-4 M system, which can be mounted on certain slitlamps (Topcon, Oakland, New Jersey, USA).
When examining the meibomian glands, a frequently assessed parameter is the extent of gland drop-out ( Figure 10A) , which defines the degree of partial or total apparent loss of the acinar tissues. Dropout may be proximal (at the contact border of the eyelid), distal (at the free margin of the eyelid), involve an entire meibomian gland ( Figure 10B ) or multiple glands ( Figure 10C ). Several grading scales for assessing meibomian gland drop-out have been proposed. 30, 109, 110 However, consensus with regard to the relative reliability of these classification systems and/or the criteria for clinically significant changes has not been clearly established. Documenting the extent of meibomian gland drop-out using photographs both at the baseline examination, and then at regular periods during lens wear, allows for clinical monitoring of any potential longitudinal changes to gland morphology. 111 Interestingly, there are conflicting reports relating to the possible association between contact lens wear and meibomian gland drop-out. 112 Changes to meibomian gland morphology have been reported to accompany contact lens wear, 30, 103 with relatively recent evidence to suggest that such changes may occur during the first couple of years of contact lens wear and remain relatively constant over longer wearing periods. The relationship between the degree of meibomian gland drop-out and tear film characteristics, including lipid layer thickness and NIBUT, is also not clearly defined. Although the extent of meibomian gland loss has been correlated with lipid layer thickness and tear stability, 113 Korb et al. have also described a lack of correlation between meibomian gland drop-out and tear lipid layer characteristics in all but the most severely affected individuals. 114 This finding may reflect meibomian gland physiology, whereby only a proportion of glands show active secretion at a given time. The effects of gland dropout may therefore depend on the affected eyelid region and not necessarily correlate with other dry eye diagnostic measures.
EVALUATION OF THE TEAR FILM AQUEOUS LAYER
The aqueous fluid is produced mostly by the lacrimal gland, with smaller contributions from the accessory lacrimal glands of Krause and Wolfring and epithelial cell secretions. 115 As the major component of the tear film bulk, the aqueous layer is the layer most variable in volume. 78 Stimulation of reflex tears can result in a 100-fold increase in flow rate over that of nonstimulated basal tears. This helps to protect the ocular surface by flushing away toxins and/or foreign bodies in the event of contamination. The aqueous tears also transfer essential nutrients, oxygen and growth factors to the avascular cornea to support maintenance and repair 116 and have antimicrobial and antioxidant constituents that act to defend against pathogens. 117 The osmolarity of the tear film is determined by the relative concentration of electrolytes, in particular sodium, chloride, potassium and bicarbonate, within the aqueous fluid; tear film proteins and sugars have little influence on tear osmolarity. 118 An increase in tear tonicity can induce cellular damage to the ocular surface tissues; tear hyperosmolarity serves as a stimulus for reflex tearing in an effort to counteract the hyperosmolarity and regain tear film homeostasis. 119 While it has been speculated that the highest tear film osmolarity values are likely to be found adjacent to sites of tear film thinning and break up on the exposed ocular surface, 120 clinicians are currently restricted to sampling from the tear meniscus for tear osmolarity measurements, which potentially moderates the true extent of the osmotic range across the ocular surface, due to repeated mixing, by blinking, with fresher isotonic tears.
Evaluation of tear volume, to assess for aqueous deficiency, is a core component of the clinical assessment of tear film integrity. 119 Identifying patients with pre-existing tear aqueous deficiency is important for assessing their potential suitability for contact lens fitting and, if deemed appropriate, to subsequently inform the lens fitting approach. In this section, we review the use of meniscometry, Schirmer test and the phenol red thread test and, for application both in the pre-and post-fitting evaluation of contact lens patients.
Meniscometry
Meniscometry involves assessing the height and/or volume of the tear meniscus, the area that acts as a reservoir for aqueous distribution into the pre-corneal film. Meniscometry can be performed non-invasively, using a range of techniques, including at the slitlamp biomicroscope, with tear interference imaging and by optical coherence tomography (OCT). A commonly assessed parameter is the tear meniscus height (TMH), which is the height of the tear film reservoir at the junction of the bulbar conjunctiva and the eyelid. TMH is typically quantified at the central aspect of the lower eyelid, immediately post-blink.
A straightforward approach to measuring TMH involves the use of en face digital slitlamp images (Figure 11 ) to derive a manual measurement. A relationship between tear osmolarity and TMH, quantified using the en face slitlamp method, has been reported in individuals with dry eye disease. 121 Anterior segment OCT can also be applied to precisely quantify various features of the tear meniscus, including its height, area and curvature. It has been proposed that an inferior TMH of less than 0.30 millimetres is consistent with dry eye, 122, 123 although TMH measures are instrument dependent, and thus a range of normative values has been suggested. Nevertheless, the presence of a lower TMH at the pre-fitting visit should alert the clinician to potential underlying aqueous deficiency and the need for clinical management.
Contact lens wear directly impacts tear meniscus characteristics. Compared to without contact lenses, lens wear significantly reduces the total volume of the tear meniscus 7 by an order of approximately one-third. 10 Total tear volume also decreases substantially from the time of lens application to end-of-day removal, 124 which appears to relate to the degree of discomfort experienced by a lens wearer. 32 The instillation of topical lubricants, with the intent of improving contact lens comfort, has been shown to enhance tear meniscus volume only transiently, for fewer than 30 minutes. 32 This finding supports subjective reports from symptomatic contact lens-wearing patients that improvements in comfort with the instillation of topical lubricants are typically temporary.
Schirmer test
The Schirmer test is historically one of the most common methods for evaluating aqueous tear production. This test is usually performed in a darkened room and involves the bilateral application of the folded end of sterile paper 'Schirmer' strips into the inferior-temporal aspect of the conjunctival sac and the patient closing their eyes for five minutes. The wetted length of the strip, from the fold crease, is then read in millimeters by the clinician. Clinically, the Schirmer test is primarily of value for identifying individuals with aqueous-deficient forms of dry eye disease and for measuring lacrimal function when performed without anaesthetic; a test score below five millimetres in five minutes is a positive diagnosis. 83 There has been limited research to investigate the effect of contact lens wear on tear production; research to date suggests that neither tear production nor turnover are significantly altered. 
Phenol red thread test
The phenol red thread test is another method for assessing tear secretion. This technique may induce less ocular irritation than the Schirmer test. The test involves the folded end of the thread being gently inserted into the lateral canthus of the inferior eyelid, at a position about one-third of the distance from the outer edge of the lid. The patient should assume a normal gaze position and maintain normal blinking for 15 seconds. The thread is pre-impregnated with a pH indicator, phenol red (phenolsulfonphthalein); when the tear film moistens the colour of the thread changes from yellow to red as a result of the tear film pH, which ranges from approximately 7.0 to 8.0. The length of red (wet) thread is measured, with a measure of 10 mm or less having high specificity (93 per cent) but low sensitivity (25 per cent), for identifying individuals with dry eye disease. 106 
EVALUATION OF THE TEAR FILM MUCIN LAYER
Tear film mucins form a protective film over the epithelial cells of the ocular surface and a reduction in their presence or functionality will be reflected in a reduction in tear film stability. Clinical diagnosis of mucin deficiency indicates the need to consider management strategies to increase goblet cell density and/or the use of mucomimetics to improve the wettability of the ocular or contact lens surface. Factors that may predispose to mucin deficiency include cicatricial ocular pemphigoid, ocular thermal and alkali burns, Sjögren's syndrome, Stevens-Johnson syndrome and vitamin A deficiency. 125, 126 Excessive mucin production can occur in conditions such as vernal keratoconjunctivitis and giant papillary conjunctivitis. 126 Impression cytology, which allows the cytological characteristics of the ocular surface to be investigated, provides an indirect measure of the amount of secreted mucin. Performing impression cytology involves applying a cellulose-acetate disc to the bulbar conjunctiva. The disc is allowed to adhere transiently to the ocular surface to allow extraction of a superficial layer of conjunctival and goblet cells, in conjunction with the tear film and mucin layer. The sample can subsequently be processed using a variety of analytical methods, including flow cytometry, microscopy and immunocytochemistry. 127 Parameters that can be quantified from conjunctival impression cytology include goblet cell density, which relates to the amount of mucin on the ocular surface, and the degree of squamous cell metaplasia. Conjunctival 128 Conjunctival impression cytology can also be used to examine epithelial cell morphology. A commonly used four-step grading system is the Nelson criteria, which is graded from zero to three, based on epithelial cell appearance and goblet cell density. 130 An alternative method for evaluating both conjunctival goblet and epithelial cells involves the use of in vivo laser scanning confocal microscopy (IVCM). This technique has the advantage of being minimally invasive to the ocular surface and provides the clinician with realtime information about the health of the ocular surface. Using a combination of IVCM and impression cytology, a recent study found that disposable hydrogel soft lenses induce a reduction in goblet cell density over six months and that this effect is exaggerated in individuals with dry eye symptoms. 33 Alterations to tear film mucins occur in response to contact lens wear. There is a decrease in the amount of secreted mucin at the ocular surface in contact lens wearers. 10 Differences in experimental approach and/or lens material may underlie conflicting reports relating to the upregulation and downregulation of transmembrane mucins, from in vitro and in vivo studies, respectively. 15 The ocular surface glycocalyx undergoes thinning and compression due to the direct physical insult of the contact lens in situ. 35 Multipurpose contact lens solutions can further adversely affect the glycocalyx layer. 36 An interesting mucin-derived effect that is specific to contact lens wear, and is considered to occur as a consequence of shear forces created between the corneal epithelial cells and contact lens with blinking, is the formation of 'mucin balls'. Mucin balls, which measure about 20-200 microns in diameter, are particulate matter that consist mostly of glycoproteins and produce temporary, spherical indentations in the corneal epithelium. 37 General consensus is that mucin balls are not a pathological finding.
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There is some evidence to suggest that the presence of mucin balls may even be associated with a decreased incidence of corneal infiltrative events during continuous wear of silicone hydrogel lenses, possibly due to the presence of a more viscous pre-corneal mucin layer. 132 
EVALUATION OF OCULAR SURFACE INTEGRITY
Blinking characteristics
Blinking is an important, semi-autonomic response that serves to remove debris from the eye, promote tear drainage, protect the eye from mechanical injury and maintain optical integrity. Through blinking, the tear film is spread, its components are replenished and its structure is restored. Blinking further promotes the secretion of meibum from the meibomian glands and the subsequent spreading of lipid across the ocular surface. A thorough clinical evaluation of the eyelids and blinking characteristics should therefore consider:
• Blink/rate frequency On average, blinking occurs 10 to 15 times per minute. Blink rate can be affected by a range of factors, including systemic conditions 133 and attentional state, for example when using a computer and reading. 134 A reduction in blink rate can be a risk factor for ocular exposure. Therefore, understanding a contact lens wearer's visual demands is important for assessing whether blink rate may be a predisposing factor for dry eye and/or ocular discomfort during lens wear.
• Blink completeness A complete blink should involve the eyelid transiently providing full coverage of the surface of the eye. In cases of incomplete blinking, there is only partial coverage of the ocular surface with blink ( Figure 12 ). The prevalence of incomplete blinking varies in individuals with healthy tears who do not wear contact lenses, but this phenomenon is frequently observed in people with dry eye disease. Qualitative examination of a patient's blinking characteristics can be undertaken by the clinician at the slitlamp. For a quantitative analysis, the LipiView II system (TearScience Inc., USA) analyses both blink rate and the frequency of partial versus complete blinks. With measurements from this system, a partial blink rate in excess of 40 per cent is considered to be indicative of potential exposure and tear lipid stagnation. In the context of contact lens wear, incomplete blinking can affect lens movement on the eye and interfere with tear film distribution on the pre-lens surface, leading to poor post-lens tear exchange and unstable vision, respectively. Full blinking is also considered important for longer-term meibomian gland health. 135 When patients are diagnosed with blink insufficiency, either due to a low blink rate or poor blink completeness, blink training can be offered; computer-based programs are commercially available for this purpose.
• Ocular Protection Index (OPI) The OPI is calculated as the ratio of the sodium fluorescein TBUT (in seconds) to the inter-blink interval (in seconds). It can be used to quantitatively evaluate the potential risk of exposure-type injury to the ocular surface, which predisposes to complications such as keratitis. An OPI of 1.0 or more is considered to be indicative of adequate ocular surface protection. 136 It has been shown that a lower OPI is associated with a higher dry eye symptom load, as measured by the Ocular Surface Disease Index questionnaire. 137 According to the OPI model, a reduction in TBUT can potentially be offset by an increase in blink rate, that is, a reduced inter-blink interval, to still provide adequate ocular surface protection. In individuals with dry eye disease and contact lens wearers with dry eye symptoms, blink frequency is increased, which is likely to represent a mechanism to compensate for the tear instability. 136 • Other eyelid abnormalities It is important to evaluate the patient for a range of other eyelid abnormalities, such as eyelid positional defects, lagophthalmos and proptosis, to consider their potential effects on contact lens wear and performance.
Ocular surface examination with vital dyes
Vital stains are frequently used in ophthalmic practice to highlight regions of ocular surface compromise, which can be identified by regions of uptake of the dye, known as 'staining'. To reduce intra-and inter-clinician grading variability, several standardised clinical scales exist to quantify the severity of ocular surface staining; these include the Efron, 138 Oxford, 139 van Bijsterveld 139, 140 and National Eye Institute (NEI) 141 scales. Sodium fluorescein ( Figure 13A ) is a water-soluble dye that fluoresces yellowgreen when excited by short wavelength, typically blue, light. For optimal fluorescence, a Wratten-12 yellow-barrier filter should be incorporated in the observation system, and a sodium fluorescein concentration of~0.08 g/L should be used. Typically, fluorescein-impregnated strips are wet with saline and gently applied to the conjunctiva. Instillation of a measured volume (1-2 μl) of sodium fluorescein can be achieved with the Dry Eye Test (DET, Amcon Laboratories, St Louis, Missouri, USA), which has been reported to improve single measurement reliability and enhanced measurement precision compared with conventional sodium fluorescein strips. 89, 142 In terms of interpreting the clinical significance of ocular surface staining with sodium fluorescein, a recent review by Bron et al. identified the potential for low amounts of corneal staining, that is, sparse punctate staining, to be evident in the healthy cornea and not necessarily indicate ocular surface pathology. These authors describe a process of physiological corneal epithelial shedding, whereby, as superficial cells are shed and are replaced by new cells, the new cells can lack a protective glycocalyx barrier leading them to 'stain' with sodium fluorescein. Corneal staining due to pathology is considered an exaggeration of this process, which occurs in association with abnormal tight-junctions between adjacent epithelial cells, and leads to more extensive epithelial cell staining. 143 Conjunctival staining is typically visualised using either lissamine green (LG) ( Figure 13B ) or rose bengal (RB) diagnostic dyes. RB is seldom used in contemporary practice as it has been linked to inducing ocular surface toxicity and induces a pronounced stinging sensation upon instillation.
LG is considered to produce a similar staining pattern to RB without the negative ocular effects, to primarily identify epithelial cells without surface glycocalyx, devitalised cells, mucous fibrils and plaques. 144 Ocular surface staining is not an infrequent finding in contact lens wearers. As reviewed in detail by Efron (2013) , corneal and conjunctival staining are nonspecific signs that can result from a diverse range of aetiological factors, including exposure, hypoxia, inflammation, infection, toxicity and/or trauma. 112 Whether there is an association between the extent of ocular surface staining and level of contact lens comfort is currently unclear. 145 
EYELID MARGIN EVALUATION
The integrity of the eyelid margin can provide indirect insight into the health of the meibomian glands and tear film.
The physical position of Marx's line can be altered as a consequence of the keratinisation process that occurs in more established MGD. Anatomically, Marx's line consists of a region of cells at the surface of the mucocutaneous junction; the line Tear film in soft contact lens wear Downie and Craig defines a transition between the palpebral conjunctiva and keratinised eyelid margin. Marx's line stains with LG and so is readily visualised at the slitlamp biomicroscope ( Figure 14) . Keratinisation can contribute to meibomian gland blockage and reduce meibum expression from the gland orifices. Its presence can induce anteroposterior migration and irregularity in the position of Marx's line ( Figure 15 ). As a consequence of this alteration, meibum secretion can become impaired or misdirected into the aqueous layer of the tear film; this perturbation to tear film structure can compromise tear film stability.
The lid wiper, another important anatomical region of the eyelid, describes a narrow area of the lid marginal conjunctiva that directly contacts the surface of the eye during blinking. Assessing the superior lid wiper region typically involves instilling sodium fluorescein and LG, or LG only, and gently lifting the lid margin to observe the staining ( Figure 16A ). The degree of staining of the lid wiper region, which reflects the amount of physical trauma to this eyelid region (so-called lid-wiper epitheliopathy [LWE]), can be graded with a four-point scale that considers both the length and width of the staining area ( Figure 16B) . 146 In addition to being a common sign in symptomatic dry eye patients, LWE is a frequent finding in soft lens wearers experiencing contact lens discomfort. 146, 147 The infiltration of Langerhans cells (dendritic cells) in the lid wiper region of people experiencing contact lens discomfort suggests an inflammatory component to the condition. 148 
OPTIMISING TEAR FILM AND OCULAR SURFACE HEALTH FOR CONTACT LENS WEAR
The previous section outlined the impact that contact lenses can have on the tear film and ocular surface. This section considers a range of clinical management options (summarised in Table 4 ) to treat tear film dysfunction and/or enhance anterior eye health in the context of fitting and providing continued care for the contact lens patient.
Management strategies are categorised by the major tear layer, that is, lipid, aqueous or mucin, targeted by each strategy. Practitioners should aim to tailor their approach to the deficiencies noted during diagnostic testing. A treatment capable of breaking the on-going cycle of tear film instability and hyperosmolarity present in contact lensinduced dry eye, will contribute significantly toward restoring normal tear function; however, often multiple therapeutic approaches are required. Clinicians are therefore encouraged to adopt as full a range of strategies as deemed clinically necessary, on the basis of the individual patient's clinical findings and their response to treatment, in order to optimise the tear film and ocular surface status.
Improving the tear film lipid layer CONFIRM THE HEALTH OF THE EYELID MARGINS AND THAT THE MEIBOMIAN GLAND ORIFICES ARE CONDUCIVE TO MEIBUM FLOW
As summarised in Table 4 , optimising eyelid margin health may involve both eyelid cleansing, in order to reduce any significant load of bacteria and/or Demodex, and debridement of the lid margin to remove keratinisation. Bacterial exotoxins are lipolytic in nature and can break down the lipid component of the tears, leading to tear film destabilisation. 149 Commensal bacteria form part of the normal microflora of the ocular adnexa, but in excessive quantities, bacterial exotoxins become sufficiently destructive to cause problems for the individual. Cleansing of the eyelid margin is typically performed by the patient at home, using commercially available eyelid wipes containing antibacterial components, or with a cotton-tipped applicator soaked in an antibacterial cleanser. Another option is for lid cleansing to be performed in-office by the clinician, using a device such as the BlephEx (Figure 17) . This instrument has a foam-tipped applicator with a spinning mechanism; the practitioner pre-moistens the foam with an eyelid cleanser and then applies the spinning end to the eyelid margin to remove eyelash crusting.
The use of eyelid cleansers is recognised to improve ocular surface signs of anterior blepharitis, as well as patient symptoms. [150] [151] [152] A wide range of surfactant-based solutions is available for eyelid hygiene, in the form of solutions, gels, foams or single-use preimpregnated wipes. Such proprietary products exhibit benefits such as custom design for safe application to the delicate periocular tissues, sterility and convenience. For these reasons, the use of diluted baby shampoo 
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Intractable cases of anterior blepharitis, which do not respond to conventional lid hygiene measures, may be due to and/or exacerbated by Demodex. Demodex are ectoparasites that live within the eyelash follicles and deep within the meibomian and eyelash sebaceous glands (Demodex brevis). Ocular demodecosis and blepharitis have a recognised association with each other; however, there is currently a lack of clarity concerning cause and effect. 156 Demodex mites are considered to induce ocular surface pathology through cellular consumption, lipolytic enzyme production and direct tissue micro-trauma; this is thought to be a stimulus for epithelial hyperplasia and reactive hyperkeratinisation of the eyelid margin. 157, 158 Reducing eyelid Demodex load is associated with improvements in eyelid signs and ocular discomfort symptoms. 159 There is currently limited scientific evidence to support the efficacies of most therapies for Demodex, aside from the topical application of tea tree oil, and possibly oral ivermectin. 160 Clinical treatment for affected individuals involves the clinician applying a 50 per cent tea tree oil solution, with a cotton-tipped applicator, to the eyelid and eyelash base once per week; this in-office therapy should be supplemented with traditional daily eyelid cleaning performed at home by the patient. As the Demodex life cycle is around 2-3 weeks, weekly treatments are recommended over at least three consecutive weeks, to ensure elimination of Demodex at its different life stages.
Hyperkeratinisation is a key feature of MGD and contributes to obstruction at the orifice of the meibomian gland. 161 It follows that removing excess keratinised material from the eyelid margin, through debridement (Figure 18 ), improves meibomian gland function, decreases ocular surface staining and reduces ocular discomfort symptoms. 161, 163 Using topical anaesthetic and lissamine green prior to the debridement treatment will assist with loosening and identifying the keratinised tissue, respectively.
Intraductal probing is a highly invasive procedure, which has been reported to offer functional improvement in the most severe cases of obstructive MGD that are unresponsive to other forms of treatment. 164, 165 Further research is required to confirm the absence of structural or • muco-mimetic artificial tears
• occlude lacrimal puncta
• debridement of eyelid margins to reduce keratinisation 2. Promote flow of meibum 2. Tear film supplementation 2. Minimise impact of contact lenses on conjunctival goblet cells
• application of controlled heat to lids to warm meibomian glands (e.g. warm compresses, intense pulsed light, Blephasteam, LipiFlow)
• aqueous-based artificial tears
• consider silicone hydrogel lenses, in preference to hydrogel soft lenses
• therapeutic meibomian gland expression (in-office)
• blinking exercises (computer-based or other)
3. Improve meibomian gland secretion quality
Reduce ocular surface inflammation
• oral supplementation with omega-3 essential fatty acids
• topical anti-inflammatory agents (e.g. corticosteroids)
• oral antibiotics (e.g. tetracyclines/ macrolides)
• artificial tears with lipid components Table 4 . Summary of key management strategies employed to improve tear film and ocular surface health Figure 17 . The BlephEx is an in-office procedure that can facilitate thorough cleansing of the eyelids Figure 18 . Excess keratinisation can be removed from the lid margin to free the meibomian gland orifices, facilitating meibum release. Topical anaesthesia helps loosen the keratinised tissue, and lissamine green helps highlight, to facilitate removal with an epithelial debrider tool (or golf club spud).
Tear film in soft contact lens wear Downie and Craig fibrotic damage, to the fragile gland structures, in the longer term.
ENCOURAGE MEIBUM FLOW FROM THE MEIBOMIAN GLANDS
In patients with MGD, there is an increase in the melting point of meibum within the meibomian glands, 166 which contributes to gland obstruction. A number of methods, most involving heat and/or assisted gland expression, 167 can be used to assist with liquefying the gland contents to promote meibum flow.
Warm compress application is the therapy most commonly recommended to patients for raising meibum temperature. Conventional advice to apply a warm, moist cloth over the eyelids has lost favour due to the potential for fast cooling of the cloth and concerns relating to contamination and inconvenience. Controlled and relatively more standardised methods for periocular heating to manage MGD include hydrating bead pouches and microwaveheated seed bags; these appliances are applied to the closed eyelids for five to 10 minutes. 168 Various products are available, including the MGDRx EyeBag (Figure 19 ), a Food and Drug Administration Class 1 medical device that can improve both patient signs and symptoms of MGD, and has been shown to possess a heating profile superior to that of a portable heating mask that utilises chemical exothermic reaction as the source of heat. 169, 170 Therapeutic expression refers to the assisted flow of meibum from the meibomian glands, achieved by pressing the eyelid between two objects, typically cottontipped applicators, fingers and/or dedicated expression devices, for example Mastrota paddle, Collins Expressor Forceps ( Figure 20) . Clinical benefits have been demonstrated by practitioner-applied therapeutic expression, but it can be a painful procedure for the patient. 171 Warming the meibomian glands prior to therapeutic expression assists with the process. 172 Furthermore, it is suggested that the procedure be performed only as clinically indicated, usually no more frequently than once per month. 173 The Blephasteam is a proprietary device that delivers moist heat to the eyelids using a sealed goggle system. Therapy with this device has been shown to provide benefits to patients with MGD, 174, 175 including improving vision quality, 176 reducing ocular bulbar redness 177 and decreasing tear evaporation rate. 178 The use of the Blephasteam is considered superior to the traditional warm cloth technique for eyelid warming. 176 A relatively newer approach to the treatment of MGD involves intense pulsed light (IPL) therapy. Craig et al. confirmed the therapeutic potential of IPL in a prospective, double-masked, placebo-controlled clinical trial. 179 A course of three treatments on days one, 15 and 45 with the EEye IPL device (E-Swin, Paris, France) ( Figure 21 ) resulted in improvements in tear film parameters (including lipid layer grade and tear film stability), accompanied by a reduction in dry eye symptoms, over the six-week treatment period. Additional support for the utility of IPL therapy for managing MGD derives from clinical retrospective reports with other devices; [180] [181] [182] however, the mechanisms underlying the effects of IPL on meibomian gland function require further research.
An alternative method for encouraging meibum flow involves applying heat to the palpebral conjunctival surface of the inner eyelids, in association with simultaneous gentle, intermittent pressure to the external eyelids. This technique, known as 'thermal pulsation,' is the basis for the LipiFlow device and promotes the liberation of lipids from the meibomian glands. The procedure, which is performed in-office, takes about 12 minutes, is not painful and may have benefits in reducing dry eye symptoms and increasing tear stability for several months after a single treatment. 183, 184 Some data suggests that the therapeutic response to thermal pulsation therapy is influenced by the extent of meibomian gland atrophy; individuals with lower degrees of meibomian gland dropout may have a result superior to those with more advanced disease. 185 Incomplete blinking (Figure 12 ) is associated with more extensive ocular surface staining and symptoms of dryness and discomfort in contact lens wearers, 15 thus it is important to encourage complete and regular blinking, particularly during screen use when the blink rate is known to be reduced. 186 Inducing an increase in Figure 19 . The MGDRx EyeBag is a commercially available device for warming the meibomian glands as part of meibomian gland dysfunction treatment Figure 20 . Therapeutic gland expression is effected by exerting pressure on the lid between a cotton-tipped applicator (anterior surface) and a Mastrota paddle (posterior surface). The cotton-tipped applicator is rolled upward on the lower margin, toward the meibomian gland orifice to encourage expression of the meibum. blinking rate has been confirmed to enhance tear stability and reduce dry eye symptoms in computer users. 187 Blinking exercises have been shown to improve gland function and reduce the frequency of incomplete blinks. 188 Ultimately, it is important that the blink rate exceeds the TBUT to allow reformation of the tear film to occur before dry spots occur within the tears; otherwise, the contact lens surface, or in the absence of a contact lens, the ocular surface, will risk exposure. The clinician should therefore strive to achieve an OPI 136 of more than 1.0 to be assured that the ocular surface is sufficiently protected.
IMPROVE THE QUALITY OF THE TEAR LIPIDS
A relevant strategy for treating MGD, particularly its more severe forms, involves the use of tetracyclines, in particular doxycycline, and topical or oral azithromycin. Tetracyclines are bacteriostatic antibiotic drugs, with broad-spectrum activity, which have anti-inflammatory effects at the doses typically prescribed for managing MGD. Tetracyclines decrease the activity of collagenases, phospholipase-A2 and a number of matrix metalloproteinases, which are implicated in the degradation of connective tissues. A five-day, pulsed dose (500 mg on the first day and then 250 mg/day) of oral azithromycin has been shown to provide an improvement in dry eye symptoms similar to that of a one-month dosing of oral doxycycline at 200 mg/day. 189 However, the mechanism of action of underlying improvements with doxycycline and azithromycin in MGD may differ 190 as divergent changes have been observed in the extent of improvement in clinical signs. 189 A further option for treating MGD, available in some parts of the world, is topical one per cent azithromycin, which reportedly reduces meibomian gland blockage and enhances the lipid characteristics of the meibum, 191 as well as reducing eyelid redness and palpebral conjunctival hyperaemia. 192 The quality of meibomian gland secretions is also influenced by the dietary intake of omega-3 (ω-3) essential fatty acids (EFAs). Omega-3 EFAs modulate systemic inflammatory pathways, which can in turn alter anterior eye inflammation, 193 and may impart neuroprotective effects in the cornea. 194 The polar lipid pattern of meibomian gland secretions in women is influenced by the dietary intake of ω-3 EFAs. 195 As recently reviewed, 196 several clinical trials have investigated the merit of oral ω-3 EFA supplements for treating dry eye disease. There is increasing evidence that ω-3 supplementation can decrease meibomian gland capping, 193 reduce the saturated fatty acid content of meibum, and attenuate symptoms, in individuals with MGD. 197 A useful supportive therapy for MGD is artificial tear products containing lipids, including mineral oils and phospholipids. While these products do not treat the underlying aetiology of MGD, lipidcontaining artificial tears can assist with increasing tear film stability and reducing tear evaporation by supplementing deficiencies in the physiological tear lipids. Some examples of these products include Optrex liposomal spray (Reckitt Benckiser), Refresh Optive Advanced (Allergan), Retaine MGD (OcuSoft), Soothe XP-Xtra Protection (Bausch and Lomb) and Systane Balance (Alcon). Lipid-containing lubricants have demonstrated benefit for improving some signs of dry eye, including lipid layer structure, tear stability and tear evaporation rate. 198 It has recently been shown that a phospholipid liposomal spray (Tears Again, bioRevive) increased tear film stability, lipid layer thickness and subjective comfort in silicone hydrogel contact lens wearers, without adversely affecting visual acuity or lipid deposits on the contact lens surface, 199 supporting the utility of these products in soft contact lens wearers.
Improving the tear film aqueous layer
The major cause of aqueous deficiency is hyposecretion of the lacrimal gland. Reduced tear aqueous results in relative hyperosmolarity of the tears, which leads to ocular surface inflammation and injury. Although aqueous insufficiency may not contraindicate contact lens wear, clinicians should carefully consider individual patient suitability for contact lens wear. This should take into account factors such as the severity of the condition, the intended contact lens wearing schedule, the most appropriate lens modality, patient motivation, systemic factors, for example Sjög-ren's syndrome, and the viability of other forms of refractive correction. For patients presenting for initial examination with symptoms and/or signs of aqueousdeficient dry eye, it is essential for appropriate management strategies to be adopted prior to initiating contact lens fitting.
Aqueous-deficient forms of tear dysfunction are often accompanied by ocular surface inflammation and therefore may require anti-inflammatory treatments. Cyclosporine-A is an immunomodulatory therapeutic that selectively inhibits T-lymphocyte activation via interleukin-2. Its ocular mode of action involves promoting greater aqueous production and enhancing goblet cell density. While the application of topical cyclosporine-A for treating dry eye disease is established, 200 there has been relatively little research undertaken to investigate the use of cyclosporine-A for reducing discomfort during contact lens wear. 201 Further research is required to determine the potential role of this therapy, for modulating tear film integrity, with the aim of enhancing comfort in contact lens wear.
Methods to promote tear retention, such as punctal occlusion, can assist with increasing resident tear aqueous volume ( Figure 22 ). In contact lens wearers, reversible punctal occlusion can increase wearing times and reduce symptoms in people experiencing soft lens discomfort. 202, 203 Occluding both the superior and inferior puncta is likely to be of more benefit than occluding only the lower punctum. 204 However, punctal occlusion should not be undertaken without some caution. In particular, management of underlying eyelid disease and/or ocular inflammation should precede occlusion of the puncta. Potential risks and complications, including infection and plug migration, should also be Figure 22 . A collagen punctal plug is inserted into the lower punctum. Collagen plugs dissolve within seven days and offer a means of trialling punctal occlusion. More permanent occlusion can be achieved with silicone punctal plugs or intracanalicular plugs.
Tear film in soft contact lens wear Downie and Craig considered and discussed with the patient during the informed consent process.
Environmental modification can also assist with reducing tear aqueous loss. The use of humidifying devices has been suggested as a potentially useful adjunct therapy to reduce tear evaporation in people with tear film instability, although there is a lack of controlled studies to confirm this effect. Moisture-chamber spectacles, which induce a local increase in humidity around the eye and aim to decrease tear evaporation, could also potentially aid with minimising aqueous loss from the tear film.
Supplementing the tears with lubricating eye-drops is another popular option for enhancing the aqueous component of the tear film; these agents are also often prescribed with the intent of improving contact lens comfort. Ocular lubricants, which include a range of hypotonic or isotonic buffered solutions, contain a variety of components, such as electrolytes, lipids and viscosity-enhancing agents. The potential benefits of lubricating eye-drops for improving contact lens comfort may derive from several factors. Lubricating eye-drops can decrease the amount of friction between the contact lens and palpebral conjunctiva, lower tear osmolarity, enhance tear retention, dilute inflammatory cytokines and/or serve to replace tear constituents that are missing from the tear film. The use of nonpreserved lubricant products will minimise the risk of inducing hypersensitivity and/or toxicity responses. 204 
Improving the tear film mucin layer
While there are numerous therapeutic products in development that may have future application for treating tear mucin deficiency, the current mainstay of therapy involves using artificial tears containing 'muco-mimetic' components. These products have a low risk of side-effects and can yield clinical improvements in tear film signs and symptoms. One example of a muco-mimetic artificial tear agent is hydroxypropyl (HP)-guar, found in Systane Ultra (Alcon), which is a pH-dependent gelling agent that is designed to assist with improving the retention of tears at the ocular surface. When instilled into the eye, HP-guar promotes the formation of a viscoelastic, gel-like matrix that is designed to promote tear film stability by forming a protective layer on the ocular surface. 205 Lubricant products incorporating HP-guar have been shown to assist with reducing dry eye symptoms and providing ocular surface protection 206, 207 and are considered to be compatible with contact lens wear. 208 
CONCLUSIONS
Soft contact lens wear has the potential to adversely affect the tear film and anterior ocular surface. As the tear film constantly interacts with a contact lens in situ, it is imperative that the quantity and quality of tears are optimised, both prior to the commencement of lens wear and to ensure continued successful contact lens wear. A comprehensive and systematic approach to clinical assessment of a patient's tear film and anterior ocular health will assist with guiding the clinician to recommend appropriate management of any tear film abnormalities, in order to maximise the likelihood of long-term contact lens fitting success.
